8 Einträge gefunden

1. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis.

   1. Lambert, Martin
   2. Conus, P
   3. Lubman, D I
   4. Wade, D
   5. Yuen, H
   6. Moritz, Steffen
   7. Naber, Dieter

   2005 - Forschungsinformationssystem des UKE
2. Randomized double blind comparison of olanzapine vs. clozapine on subjective well-being and clinical outcome in patients with schizophrenia.

   1. Naber, Dieter
   2. Riedel, M
   3. Klimke, A
   4. Vorbach, E-U
   5. Lambert, Martin
   6. Kühn, K-U
   7. Bender, S

   2005 - Forschungsinformationssystem des UKE
3. Diagnostic stability 18 months after treatment initiation for first-episode psychosis.

   1. Schimmelmann, Benno G
   2. Conus, Philippe
   3. Edwards, Jane
   4. McGorry, Patrick D
   5. Lambert, Martin

   2005 - Forschungsinformationssystem des UKE
4. Comparison of olanzapine and risperidone in 367 first-episode patients with non-affective or affective psychosis: results of an open retrospective medical record study.

   1. Lambert, Martin
   2. Conus, P
   3. Schimmelmann, B G
   4. Eide, P
   5. Ward, J
   6. Yuen, H
   7. Schacht, M

   2005 - Forschungsinformationssystem des UKE
5. Subjective well-being under the neuroleptic treatment and its relevance for compliance.

   1. Naber, Dieter
   2. Karow, Anne
   3. Lambert, Martin

   2005 - Forschungsinformationssystem des UKE
6. PANSS syndromes and quality of life in schizophrenia.

   1. Karow, Anne
   2. Moritz, Steffen
   3. Lambert, Martin
   4. Schoder, S
   5. Krausz, M

   2005 - Forschungsinformationssystem des UKE
7. Subjective distress related to side effects and subjective well-being in first admitted adolescents with early-onset psychosis treated with atypical antipsychotics.

   1. Schimmelmann, Benno Graf
   2. Paulus, Stephanie
   3. Schacht, Melanie
   4. Tilgner, Christian
   5. Schulte-Markwort, Michael
   6. Lambert, Martin

   2005 - Forschungsinformationssystem des UKE
8. Olanzapine vs. other antipsychotics in actual out-patient settings: six months tolerability results from the European Schizophrenia Out-patient Health Outcomes study.

   1. Lambert, Martin
   2. Haro, J M
   3. Novick, D
   4. Edgell, E T
   5. Kennedy, L
   6. Ratcliffe, M
   7. Naber, Dieter

   2005 - Forschungsinformationssystem des UKE